Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
16 Juni 2021 19:20:26
Amoxicillin na ujauzito
Amoxicillin ni antibayotiki kundi la aminopenicillin inayofanana sana na ampicillin, dawa hii inafahamika kuingia kwa mtoto wakati bado yupo tumboni mwa mama.
Tafiti nyingi zimeelezea matumizi ya amoxicillin na potassium clavulanate ( kwa jina jingine amoxiclavu au amoxicillin–clavulanic) kutibu maambukizi mbalimbali kwa mama mjamzito. Tafiti nyingi zimeonyesha kutokuwepo kwa madhara kwa kijusi na mtoto anayezaliwa. Hata hivyo tafiti moja imeripoti kuwa kuna mahusiano kati ya matumizi ya dawa hii na kutokea kwa ugonjwa wa kuoza kwa utumbo wa mtoto kwa vichanga wanaozaliwa.
Ushauri dhidi ya matumizi kwa mama mjamzito
Inapatana na ujauzito
Inapatana na ujauzito ina maanisha nini?
Uzoefu wa matumizi kwa binadamu kuhusu dawa hii au dawa zingine zilizo kundi moja au zenye kufanya kazi kwa utaratibu unaofanana, zinatosha kuonyesha kuwa, madhara kwa kichanga tumboni ni madogo sana au hakuna kabisa. Tafiti za uzazi kwa wanyama hazina uhalisia kwa binadamu.
Ushauri wa matumizi kwa mama anayenyonyesha
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji ina maanisha nini?
Hakuna taarifa za uzoefu kuhusu matumizi ya dawa hii kwa mama anayenyonyesha au kuna taarifa chache. Taarifa chache zilizopo zinaonyesha kuwa dawa hii haiwasilishi hatari yenye mashiko kwa kichanga anayenyonya maziwa ya mama anayetumia dawa.
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
22 Aprili 2022 15:50:30
Rejea za mada hii;
1. Product information. Amoxil. SmithKline Beecham Pharmaceuticals, 2000.
2. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977.
3. Masterton RG, Evans DC, Strike PW. Single-dose amoxycillin in the treatment of bacteriuria in pregnancy and the puerperium—a controlled clinical trial. Br J Obstet Gynaecol 1985;92:498–505.
4. Jakobi P, Neiger R, Merzbach D, Paldi E. Single-dose antimicrobial therapy in the treatment of asymptomatic bacteriuria in pregnancy. Am J Obstet Gynecol 1987;156:1148–52.
5. Almeida L, Schmauch A, Bergstrom S. A randomised study on the impact of peroral amoxicillin in women with prelabour rupture of membranes preterm. Gynecol Obstet Invest 1996;41:82–4.
6. Magwali TL, Chipato T, Majoko F, Rusakaniko S, Mujaji C. Prophylactic augmentin in prelabor preterm rupture of the membranes. Int J Gynecol Obstet 1999;65:261–5.
7. Magat AH, Alger LS, Nagey DA, Hatch V, Lovchik JC. Double-blind randomized study comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Obstet Gynecol 1993:81:745–9.
8. Alary M, Joly J-M, Mondor M, Boucher M, Fortier A, Pinault J-J, Paris G, Carrier S, Chamberland H, Bernatchez H, Paradis J-F. Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydia infection in pregnancy. Lancet 1994;344:1461–5.
9. Turrentin MA, Newton ER. Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obstet Gynecol 1995;86:1021–5.
10. Kenyon SL, Taylor DJ, Tarnow-Mordi W, for the ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001;357:979–88.
11. Jepsen P, Skriver MV, Floyd A, Lipworth L, Schønheyder HC, Sørensen HT. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. Br J Clin Pharmacol 2003;55:216–21.
12. Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, Bortnik O, Arnon J. Ornoy A. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 2004;58:298–302.
13. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer SM, Gideon PS, Hall KS, Kaltenbach LA, Ray WA. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009;23:18–28.
14. Lin KJ, Mitchell AA, Yau W-P, Louik C, Hernandez-Diaz S. Maternal exposure to amoxicillin and the risk of oral clefts. Epidemiology 2012;23:699–705.
15. Kafetzis D, Siafas C, Georgakopoulos P, Papadatos C. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand 1981;70:285–8.
16. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993;168:1393–9.
17. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89.